Literature DB >> 11717151

Sphingolipid mediators in cardiovascular cell biology and pathology.

T Levade1, N Augé, R J Veldman, O Cuvillier, A Nègre-Salvayre, R Salvayre.   

Abstract

Sphingolipids have emerged as a new class of lipid mediators. In response to various extracellular stimuli, sphingolipid turnover can be stimulated in vascular cells and cardiac myocytes. Subsequent generation of sphingolipid molecules such as ceramide, sphingosine, and sphingosine-1-phosphate, is followed by regulation of ion fluxes and activation of various signaling pathways leading to smooth muscle cell proliferation, endothelial cell differentiation or apoptotic cell death, cell contraction, retraction, or migration. The importance of sphingolipids in cardiovascular signaling is illustrated by recent observations implicating them in physiological processes such as vasculogenesis as well as in frequent pathological conditions, including atherosclerosis and its complications.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11717151     DOI: 10.1161/hh2301.100350

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  37 in total

1.  G protein-independent inhibition of GIRK current by adenosine in rat atrial myocytes overexpressing A1 receptors after adenovirus-mediated gene transfer.

Authors:  Leif I Bösche; Marie-Cécile Wellner-Kienitz; Kirsten Bender; Lutz Pott
Journal:  J Physiol       Date:  2003-06-18       Impact factor: 5.182

2.  Sphingosine 1-phosphate activates Weibel-Palade body exocytosis.

Authors:  Kenji Matsushita; Craig N Morrell; Charles J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-23       Impact factor: 11.205

3.  Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats.

Authors:  D G Hemmings; Y Xu; S T Davidge
Journal:  Br J Pharmacol       Date:  2004-08-23       Impact factor: 8.739

4.  Ceramide signaling in the coronary microcirculation: a double-edged sword?

Authors:  Brian R Weil; John M Canty
Journal:  Circ Res       Date:  2014-08-15       Impact factor: 17.367

Review 5.  Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology.

Authors:  Catherine Pavoine; Françoise Pecker
Journal:  Cardiovasc Res       Date:  2009-01-28       Impact factor: 10.787

6.  Exogenous and endogenous ceramides elicit volume-sensitive chloride current in ventricular myocytes.

Authors:  Frank J Raucci; Dayanjan S Wijesinghe; Charles E Chalfant; Clive M Baumgarten
Journal:  Cardiovasc Res       Date:  2009-12-14       Impact factor: 10.787

7.  Omega-3 polyunsaturated fatty acids delay the progression of endotoxic shock-induced myocardial dysfunction.

Authors:  David Coquerel; Eva Kušíková; Paul Mulder; Moïse Coëffier; Sylvanie Renet; Pierre Dechelotte; Vincent Richard; Christian Thuillez; Fabienne Tamion
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

8.  The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity.

Authors:  John W Newman; Christophe Morisseau; Todd R Harris; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

Review 9.  Sphingolipid therapy in myocardial ischemia-reperfusion injury.

Authors:  Susheel Gundewar; David J Lefer
Journal:  Biochim Biophys Acta       Date:  2007-09-06

10.  Myriocin-mediated up-regulation of hepatocyte apoA-I synthesis is associated with ERK inhibition.

Authors:  Elias N Glaros; Woojin S Kim; Brett Garner
Journal:  Clin Sci (Lond)       Date:  2010-03-30       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.